OPIOID REPLACEMANT THERAPY: AN OVERVIEW
|
|
- Elaine Benson
- 5 years ago
- Views:
Transcription
1 OPIOID REPLACEMANT THERAPY: AN OVERVIEW Matthew Felgus MD FASAM Matthew A Felgus, MD, FASAM mafelgus@wisc.edu matthewfelgusmd.com 6333 Odana Rd, Ste 3, Madison WI (608) Board Certified in Addiction Medicine Board Certified in Psychiatry Learning Objectives Understand the various types of medication assisted treatment for Opioid Use Disorder Understand the positives and drawbacks of each type of medication assistance Understand the necessary treatment in addition to medication for Opioid Use Disorder 1
2 Full mu agonists Oxycodone Hydrocodone Hydromorphone Fentanyl series HEROIN Methadone Morphine Meperidine Oxymorphone Codeine Opioids Partial mu agonist Buprenorphine Mixed Agonist/Antagoni st Pentazocine Butorphanol Nalbuphine Tramadol (Ultram) AND ALL ARE ADDICTIVE Opioid Metabolism 2
3 Opioids: The Science Opioid Receptor Subtypes Mu : euphoria, causes withdrawal Kappa: pain control, no euphoria Delta: feeling good Lambda Opioids: The Science All animals have opioid receptors throughout their brains Related to survival of the species Opioids do not eliminate pain, but decrease the arousal that accompanies pain Cause an increase in norepinephrine Endorphins: self-produced opioid compounds Opioids: The Science CNS depressant similar to effects of alcohol Greatest risk is of respiratory depression Opioid + Benzodiazepine = recipe for an overdose ENERGY from an opioid = brain wiring for addiction 3
4 Poll Question 1 Which of the following are warning signs that someone could become addicted to their opioid medication? Family history of alcoholism Drinking 7 or more drinks per week High current life stressors (e.g. divorce) History of high anxiety Poll Question 2 Which of the following are warning signs that someone could become addicted to their opioid medication? History of past trauma Past history of alcohol dependence Concurrent use of a benzodiazepine Cannabis use 2-3x/week BEFORE YOU START OPIOIDS: Past overuse of CNS depressants (alcohol or benzodiazepines) increase the risk of opioid overuse. Likely a greater risk than overuse of other substances (cocaine, cannabis) but both MD and patient must maintain awareness History of family members becoming ENERGIZED from opioid medication Greater than 7 drinks per week (not rare in WI) 4
5 Education not Punishment Higher risk factors does NOT mean someone is intending to abuse their opioid medication Sometimes it is necessary to utilize opioid medication and this should be done as safely as possible Nobody starts using anything planning to develop an addiction Educating the patient/client that they are higher risk in a non-judgmental way can make a major difference ENERGIZED by Opioids Most people become tired, nauseous, cloudy after taking an opioid Some people become energized This appears to be a genetic variation ( does run in families) This will likely occur at first exposure (including in children) Education to this risk factor is key to preventing addiction ENERGIZED by Opioids Positive Reinforcement: If it makes you feel good, you re going to do it again. And again This is a major risk factor for addiction to opioids People who develop an opioid addiction often say they had no idea this could happen to them (may be otherwise upstanding citizens) 5
6 <3 Min Conversation for ALL Patients Prior to Opioid Rx If you feel energized after taking this medication, you need to call the office. This shows you may have the brain wiring to develop an addiction to this type of pain medication. It is based on genetics and isn t anything you are doing wrong. It is not about willpower or good character. It can happen to anybody with this type of brain wiring and most people don t know they have it until they take this kind of prescription. However, you need to be very cautious with any opioids never take extra and, if you can, have somebody else hold it. Opioid Withdrawal Syndrome Elevated pulse rate/blood pressure Perspiration Restlessness Pupil Dilation Joint Aches Muscle Aches GI Cramping Tremor Yawning Anxiety Goosebumps Runny nose Watery Eyes Nausea/Vomiting Opioid Withdrawal Syndrome Assessment Grade 1 lacrimation, rhinorrhea, yawning, insomnia, agitation, diaphoresis Grade 2 arthralgias, myalgias, abdominal cramps, muscle twitches Grade 3 tachycardia, hypertension, tachypnea, fever, anorexia, nausea, severe restlessness Grade 4 diarrhea, vomiting, dehydration, hyperglycemia 6
7 Opioid Withdrawal Onset and Peak symptoms dependent on opioid or opiate abused Variable to the individual Heroin - onset 8 hours with peak symptoms 24 to 48 hours after last use Methadone - onset 24 to 48 hours with peak symptoms within 48 to 96 hours after last use Subjective symptoms may persist for weeks WHY? GENETIC VULNERABILITY + STRESSOR Oxycontin (OC) Controlled release of oxycodone hydrochloride Introduced in late 1990s Usually crushed or chewed in abuse (rapid release) Dramatic increase in use from 1999 Something about this opiate seemed more abused than the others = more euphoria Formulation changed 2010 to prevent abuse but users adapted 7
8 Oxycontin (OC) A 2010 change in a controlled release formulation of oxycodone (OxyContin, Purdue Pharma) that was intended to prevent abuse of the prescribed opioid has had the unintended consequence of causing many abusers to switch to heroin, new research shows. Medscape July, 2012 Heroin Use 90% white >50% employed 89% High school diploma or beyond Intranasal use is most common 2014 National Survey on Drug Use and Health Case Study Rebecca is a 30 year old student/ waitress with a 10+ year history of opioid dependence, primarily heroin. She has been in and out of treatment, both residential and outpatient at least 15 times. Treatments have included both methadone and buprenorphine but she has never gone longer than 6 months without heroin. 8
9 Case Study Rebecca has had social anxiety since middle school and experiences panic attacks several times per week. She has taken medication and had weekly therapy for years, as well as involvement in yoga and other relaxation techniques. Case Study She reports that the panic attacks cause her to fear she is going to die. Both her job and sitting in class worsen the social anxiety, which leads to more panic attacks. Despite not wanting to relapse, it feels as though heroin is the only thing that relieves her anxiety even for a night. Case Study Rebecca can t stay off heroin until her anxiety is managed She can t manage her anxiety while in the cycle of relapse 9
10 The Mental Health Big 4 for Driving Addiction Anxiety Trauma Depression Insomnia Opioids and Anxiety Extremely common presentation High degree of overlap between withdrawal and anxiety sxs While anxiety isn t responsible for the opiate epidemic, it is a major barrier for individuals to stop using Opioids and Anxiety Opioids are wonderful numbing agents and individuals with anxiety (and PTSD) want to be numbed We as treaters need to be more mindful of our messages about anxiety 10
11 Opioid Withdrawal Increased BP Increased HR Sweating/Chill s/hot flashes Restlessness Dilated Pupils GI Cramps/ Gooseflesh Diarrhea Runny Nausea/Vo nose/wa miting tery eyes Feeling of Dying Tremor Yawning Bone Pain Muscle Aches Anxiety Increased BP ness Increased HR Sweating/Chills/Hot flashes Heart attack feeling/chest pain Restlessness Shortness of GI Cramps/Diarrhea Breath/Smothering/ Choking Shaking/Tremor Room closing in Inability to Concentrate Fear of going crazy/dying Out of Body Depersonalization/Numb Dizzy/Lightheaded/Tingli ng Anxiety or Withdrawal: How to Treat? Avoid addictive medications (NO BENZODIAZEPINES!) Focus on treatment of symptoms: Sleep, Anxiety, GI upset Even if a pt is getting support for their recovery (MD, AA/NA) please treat their mental health 11
12 Medication Assisted Tx for Opioid Dependence Buprenorphine (e.g. Suboxone ) Naltrexone (oral or IM- Vivitrol ) Methadone Opioid Replacement: WHY? OPIOID USE HAS EXPLODED AND SHOWS NO SIGN OF SLOWING!!! Buprenorphine Partial mu agonist with high affinity Will displace any other mu agonist precipitating withdrawal Buprenex - injectable form - only indication is for analgesia Subutex 2 & 8mg sublingual tablets buprenorphine Suboxone Buprenorphine/naloxone combination 2/0.5mg, 4/1mg, 8/2mg & 12/3 mg sublingual films. Also, available in generic 2mg and 8mg pills 12
13 Buprenorphine/Naloxone Zubsolv -- Buprenorphine/naloxone combination 0.7/0.18mg, 1.4/0.36 mg, 2.9/.71mg,5.7/1.4 mg, 8.6/2.1mg Equivalent to 1, 2, 4, 8, and 12 mg suboxone dosages Better bioavailability (so lower amount of bup) Pills tend to crumble when cut Buprenorphine/Naloxone Bunavail -- Buprenorphine/naloxone combination 2.1/0.3mg,4.2/0.7mg, 6.3/1mg (equal to 4, 8 and 12 mg suboxone) Sticks to inside of cheek Better bioavailability? Not recommended to cut in order to taper Buprenorphine/Naloxone Dosage Range: not agreed upon Research shows receptors saturated at 16mg although some prescribers go MUCH higher Manufacturer does NOT recommend >24 Quick detox vs. slow (1-5+yr.) detox vs. maintenance Is it possible to taper off without relapse? 13
14 Buprenorphine/Naloxone Half-life is hours (average 35 hrs.) so only needed once daily Safer in OD since less respiratory depression than other opioids Best if used as past of a treatment program Buprenorphine/ Naloxone Yes, you can get high.if not opioid dependent Diversion of prescription Party drug for those without an opioid habit Prevention of opioid withdrawal in those using Self detox for those trying to quit Buprenorphine/Naloxone MDs take an 8 hour class to prescribe NPs take a 24 hour class to prescribe Not enough prescribers for demand? No addiction training needed 14
15 Buprenorphine/Naloxone 30 Patient Cap at initial license 100 Patient Cap after 1 year 275 Patient Cap increase as of 2016 for specialists Better access vs. increase in buprenorphine mills? Buprenorphine: WHY? Effective, proven treatment in reducing use Buprenorphine: WHY? Effective, proven treatment in reducing use Keeps clients in treatment (carrot) 15
16 Buprenorphine: WHY? Effective, proven treatment in reducing use Keeps clients in treatment (carrot) Blocking agent for other opioids Buprenorphine: WHY? Effective, proven treatment in reducing use Keeps clients in treatment (carrot) Blocking agent for other opioids Less likely to be abused (but not impossible) Buprenorphine: WHY? If used properly (lowering doses) clients can be tapered off opioids 16
17 Buprenorphine: WHY? If used properly (lowering doses) clients can be tapered off opioids This is important with a younger population Buprenorphine: WHY? If used properly (lowering doses) clients can be tapered off opioids This is important with a younger population One component of a well-rounded treatment program Buprenorphine: WHY NOT? Over reliance on medication vs. recovery tools 17
18 Buprenorphine: WHY NOT? Over reliance on medication vs. recovery tools Doses can be too high (clients appear stoned.) This is less likely than with methadone Buprenorphine: WHY NOT? Over reliance on medication vs. recovery tools Doses can be too high (clients appear stoned.) This is less likely than with methadone Establishing a potential lifelong dependence on opioid medications Buprenorphine: WHY NOT? Opioid Replacement for a less severe habit (may be started at a higher dose than the amount of street opioid used) 18
19 Buprenorphine: WHY NOT? Opioid Replacement for a less severe habit (may be started at a higher dose than the amount of street opioid used) It is possible to abuse opiate replacement meds (methadone and suboxone) Buprenorphine: WHY NOT? Opioid Replacement for a less severe habit (may be started at a higher dose than the amount of street opioid used) It is possible to abuse opiate replacement meds (methadone and suboxone) Diversion to street Methadone What does it do? Stops withdrawal and craving Blocks effects of other opioids Reduces drug use and criminal activity to acquire drugs Decreases HIV, safer in pregnancy than street opioids 19
20 Methadone In use since 1960s Must be given in a licensed clinic (expect if used for pain treatment) Can be overdosed At high doses, individuals can appear to nod out Rationale: Methadone It works to stop use of other opioids It lowers IVDU It is oral, long-acting (but still controversial and highly regulated) Methadone May be used for detox or maintenance Starting dose 30mg May give an additional 10mg first 24 hours Maintenance doses vary: mg A physician may continue to administer methadone for a patient during a hospitalization; otherwise must be given in a clinic if for addiction treatment 20
21 Methadone Yes, you can get high Are high doses (>150 mg.) necessary to maintain abstinence OR treating sxs of other disorders (dep, anx)? OR BOTH?? Why are we as treaters so avoidant of discomfort of withdrawal solely in this population? Opioid Receptor Blockade Naltrexone Oral Daily Vivitrol Injection of naltrexone Lasts 4 weeks Naltrexone (oral) Approved in 1994 for treatment of alcohol dependence Decreases alcohol consumption by likely blocking positive reinforcing effects Blocks opioid receptors Biggest challenge is compliance (continuing medication) 21
22 Naltrexone Side Effects Nausea Sleepiness Abnormal rise in liver enzymes Mood blunting or depression/lack of runner s high type of feeling possible (less likely with injection) Vivitrol Injectable form of Naltrexone Blocks effects of opioids for 4 weeks More residential treatment programs + corrections offering this option at discharge Alternative to Replacement Therapy as can not be combined with opioids including suboxone Good option for motivated individuals Vivitrol Concerns Injection does not always last 4 weeksmay wear off in 3 1/2 weeks but insurance will not cover early injection Pain medication may not be as effective (accident or emergent surgery) Must have NO opioids in system for 7-14 days in order to start 22
23 Vivitrol Concerns Mood blunting or depression/lack of runner s high type of feeling Shift to abuse of another substance (alcohol, meth) Monthly injection makes it easy not to do other treatment Injectable Naltrexone: WHY? It s not an opioid Injectable Naltrexone: WHY? It s not an opioid It can not be abused (no high) 23
24 Injectable Naltrexone: WHY? It s not an opioid It can not be abused (no high) No street value Injectable Naltrexone: WHY? It s not an opioid It can not be abused (no high) No street value It saves lives Injectable Naltrexone: WHY? It s not an opioid It can not be abused (no high) No street value It saves lives Injection as leaving incarceration or rehab does help prevent overdose 24
25 Injectable Naltrexone: WHY NOT? Injection is expensive ($ /vial) Injectable Naltrexone: WHY NOT? Injection is expensive ($ /vial) Not an opioid and does not numb feelings (still can have cravings) Injectable Naltrexone: WHY NOT? Injection is expensive ($ /vial) Not an opioid and does not numb (still can have cravings) May be done under duress 25
26 Injectable Naltrexone: WHY NOT? Injection is expensive ($ /vial) Not an opiate and does not numb (still can have cravings) May be done under duress Patients may try to overcome block as injection wears off and overdose In Summary: Addiction is a disorder of brain wiring that turns into a drive to numb out Shame is a major part of addiction We can not make anybody ready for treatment We can offer options for treatment along with compassion and good boundaries Final Thoughts Nearly all individuals who become addicted are trying to numb something, and need our help to learn to feel again Medication alone will not solve the issue of substance abuse and addiction but may be one piece of the puzzle 26
27 Final, Final thoughts Healing is a s-l-o-w process and relapse is the rule rather than the exception The medical profession has a lot to learn about the above, and the majority of MDs are not trained in treating addictions THANK YOU 27
Opioid Replacement Therapy
Opioid Replacement Therapy Matthew A. Felgus, MD mafelgus@wisc.edu 6333 Odana Rd, Suite 3, Madison, WI 53719 (608) 257-1581 Board Certified in Addiction Medicine Board Certified in Psychiatry matthewfelgusmd.com
More informationMEDICATION Assisted Treatment
Matthew A Felgus, MD FASAM mafelgus@wisc.edu matthewfelgusmd.com 6333 Odana Rd, Ste 3, Madison WI 53719 (608) 257-1581 Board Certified in Addiction Medicine Board Certified in Psychiatry MEDICATION Assisted
More informationADOLESCENTS, YOUNG ADULTS AND OPIOID USE: WHEN IS IT A PROBLEM? WHAT TO DO?
ADOLESCENTS, YOUNG ADULTS AND OPIOID USE: WHEN IS IT A PROBLEM? WHAT TO DO? HOSTED BY: ADOLESCENT SBIRT PROJECT, NORC at THE UNIVERSITY OF CHICAGO, and THE BIG SBIRT INITIATIVE Webinar Moderator Tracy
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationThe Interface Between Substance Use and Mental Health
The Interface Between Substance Use and Mental Health (How to Not Get Tangled Up) Matthew A Felgus, MD, FASAM mafelgus@wisc.edu 6333 Odana Rd, Ste 3, Madison WI 53719 (608) 257-1581 Board Certified in
More informationRecovery U: Medication Assisted Treatment (MAT)
Recovery U: Medication Assisted Treatment (MAT) MS. TIKKANEN: Welcome to the Recovery U Online Learning Community for Understanding Medication-Assisted Treatment. This is Skye Tikkanen. I am a clinical
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationOpioids Research to Practice
Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin
More informationDeveloped and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services
Developed and Presented by Randall Webber, MPH, CADC JRW Behavioral Health Services www.randallwebber.com MAT clients are still addicted Truth: MAT clients will experience withdrawal symptoms if they stop
More informationOpioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine
Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene
More informationBuprenorphine pharmacology
Buprenorphine pharmacology Victorian Opioid Management ECHO Department of Addiction Medicine St Vincent s Hospital Melbourne 2018 Page 1 Opioids full, partial, antagonist Full Agonists - bind completely
More informationMedication-Assisted Treatment (MAT) Overview
Medication-Assisted Treatment (MAT) Overview 2014 Opiate Conference: Don t Get Me Started Hyatt Regency, Columbus, Ohio June 30-July 1, 2014 Christina M. Delos Reyes, MD Medical Consultant, Center for
More informationModule II Opioids 101 Opiate Opioid
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!
More informationOpioids Research to Practice
Opioids Research to Practice May 2013 Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Assistant Dean, Continuing Medical Education Case 32 yo female brought in after heroin overdose
More informationMedication Assisted Treatment. MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment
Medication Assisted Treatment MAT Opioid dependence/addiction Opioid treatment programs OTP Regulation of OTP Office Based Treatment Opioid Drugs Opium Morphine Heroin Codeine Oxycodone Roxycodone Oxycontin
More informationSubstitution Therapy for Opioid Use Disorder The Role of Suboxone
Substitution Therapy for Opioid Use Disorder The Role of Suboxone Methadone/Buprenorphine 101 Workshop, December 10, 2016 Leslie Lappalainen, MD, CCFP, dip ABAM Prepared by Mandy Manak, MD, ABAM, CCSAM
More informationPrescription Opioid Addiction
CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett
More informationMedications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?
Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives
More informationMedication Assisted Treatment
Meeting the Needs of Your Clients: Building Competencies in Mental Health and Addiction Services Medication Assisted Treatment November 5, 2018 In partnership with: House Keeping Because this is a webinar,
More informationRecognizing Narcotic Abuse and Addiction and Helping Those With It
Recognizing Narcotic Abuse and Addiction and Helping Those With It Michael McNett, MD Medical Director for Chronic Pain Member, WI Med Society Opioid Subcommittee Ancient History 1995: OxyContin approved
More informationAND HOW TO TREAT THEM MATTHEW FELGUS, MD; SKYE TIKKANEN, MS, NCC, CSAC, LPC, CS-IT. Matthew Felgus, MD 9/29/16
MENTAL HEALTH PROBLEMS CO- OCCURRING WITH SUBSTANCE USE DISORDERS AND HOW TO TREAT THEM MATTHEW FELGUS, MD; SKYE TIKKANEN, MS, NCC, CSAC, LPC, CS-IT Dual Diagnosis: The Interface Between Substance Abuse
More informationOpioids Research to Practice
Opioids Research to Practice CRIT/FIT 2016 April 2016 Daniel P. Alford, MD, MPH Associate Professor of Medicine Assistant Dean, Continuing Medical Education Director, Clinical Addiction Research and Education
More informationOpioid Dependence and Buprenorphine Management
Opioid Dependence and Buprenorphine Management Kevin Kapila, MD Fenway Health Medical Director of Behavioral Health Instructor in Medicine Harvard Medical School Learning Objectives Understand the rationale
More informationOpioids. October 29, Addiction Medicine Review Course CSAM, Newport Beach, CA
Opioids October 29, 2010 Addiction Medicine Review Course CSAM, Newport Beach, CA Daniel P. Alford, MD, MPH, FACP, FASAM Associate Professor of Medicine Boston University School of Medicine Boston Medical
More informationSW OREGON OPIOID SUMMIT. Medication Assisted Recovery for Opioid Use Disorder. Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass
SW OREGON OPIOID SUMMIT Medication Assisted Recovery for Opioid Use Disorder Gregory S. Brigham, Ph.D. Adapt / SouthRiver CHC / Compass Opioid Agonists Mu (μ) receptors stimulated by opioids causing full
More informationAn overview of Medication Assisted Treatment (MAT) and acute pain management on MAT
An overview of Medication Assisted Treatment (MAT) and acute pain management on MAT Goals of Discussion Recognize opioid use disorder (OUD) Discuss the pharmacology of medication assisted treatments (MAT)
More informationOpioid dependence and buprenorphine treatment
Opioid dependence and buprenorphine treatment David Roll, MD Revere Family Health, Cambridge Health Alliance Instructor in Medicine, Harvard Medical School Joji Suzuki MD Medical Director of Addictions
More informationDisclosures. Topics of today s training 4/24/2017. Evolving Treads in Medication Assisted Treatment. Christopher J Davis D.O.
Evolving Treads in Medication Assisted Treatment Christopher J Davis D.O. CAADC, FASAM Medical Director, The Ranch of Pennsylvania Medical Director, Pyramid Healthcare Diplomate of The American Board of
More informationMedication Assisted Treatment. Michael Palladini, RPh MBA CAC
Medication Assisted Treatment Michael Palladini, RPh MBA CAC palladini.michael@gmail.com History of MAT Addiction as a Disease The concept of addiction as a disease of the brain challenges deeply ingrained
More informationA prisoners guide to buprenorphine
A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw
More informationTopics of today s training
Extended Release Naltrexone Vivitrol Christopher J Davis D.O. CAADC, FASAM Medical Director, Brightwater Landing Medical Director, Pyramid Healthcare Diplomate of The American Board of Addition Medicine
More informationSUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION
SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place
More informationten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment
ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots
More informationMedication-Assisted Treatment. What Is It and Why Do We Use It?
Medication-Assisted Treatment What Is It and Why Do We Use It? What is addiction, really? o The four C s of addiction: Craving. Loss of Control of amount or frequency of use. Compulsion to use. Use despite
More informationMEDICATION ASSISTED TREATMENT
MEDICATION ASSISTED TREATMENT MODULE 14 ALLIED TRADES ASSISTANCE PROGRAM PREVENTATIVE EDUCATION: SUBSTANCE USE DISORDER Medication Assisted Treatment Types of Medication Assisted Treatment: Methadone Naltrexone
More informationDisclosure Statement. Learning Objectives. American Psychiatric Nurses Association. Christian J. Teter, PharmD, BCPP 1 BUPRENORPHINE UPDATE
BUPRENORPHINE UPDATE Christian J. Teter, Pharm.D., BCPP Associate Professor, Psychopharmacology College Of Pharmacy, University Of New England Portland, ME E-Mail: cteter@une.edu Image Source: pubchem.ncbi.nlm.nih.gov
More informationOpioid Use Disorders as a Brain Disease Why MAT is so important. Ron Jackson, M.S.W., L.I.C.S.W.
Opioid Use Disorders as a Brain Disease Why MAT is so important Ron Jackson, M.S.W., L.I.C.S.W. Affiliate Professor School of Social Work University of Washington Organization Name: CareOregon Course Title:
More informationWasted AN INTRODUCTION TO SUBSTANCE ABUSE
Wasted AN INTRODUCTION TO SUBSTANCE ABUSE Dr. Brian L. Bethel Child and Family Therapist Independent Trainer and Consultant LPCC-S, LCDC III, RPT-S www.brianlbethel.com INTERPLAY COUNSELING & CONSULTING
More informationVivitrol Vs. Suboxone
Vivitrol Vs. Suboxone Vivitrol - Naltrexone Indicated for opiate dependence and alcohol withdrawal pure antagonist 380mg once every 4 weeks IM Peak plasma concentration in 2 hrs, followed by a second peak
More information9/13/2017. Buprenorphine Treatment (Suboxone) Disclosures. We ve Got a Big Opioid Problem. Selahattin Kurter, MD Spectrum Healthcare
Buprenorphine Treatment (Suboxone) Selahattin Kurter, MD Spectrum Healthcare Board Certified in Psychiatry and Addiction Medicine Disclosures No financial reimbursement for this lecture Consultant for
More informationPeople inject, sniff, snort, or smoke heroin. Some people mix heroin with crack cocaine, a practice called speedballing.
What is heroin? Heroin is an opioid drug made from morphine, a natural substance taken from the seed pod of the various opium poppy plants grown in Southeast and Southwest Asia, Mexico, and Colombia. Heroin
More informationSUBOXONE TREATMENT PROGRAM
SUBOXONE TREATMENT PROGRAM What is Suboxone? Suboxone is a medication used for the treatment of addiction to prescription pain medication, heroin addiction, methadone or other opioid dependence. The primary
More informationOpioids. Sergio Hernandez, MD
Opioids Sergio Hernandez, MD Required Slide Disclosures 1. SIGNIFICANT FINANCIAL INTERESTS NO SIGNIFICANT FINANCIAL, GENERAL, OR OBLIGATION INTERESTS TO REPORT 2. GENERAL AND OBLIGATION INTERESTS All general
More informationAODA RECOVERY. How to support those in recovery, and those not yet ready to commit
AODA RECOVERY How to support those in recovery, and those not yet ready to commit YOUR PRESENTER TODAY Robin Lickel is a psychotherapist and addictions specialist at Journey Mental Health Center in Madison,
More informationTalking with your doctor
SUBOXONE (buprenorphine and naloxone) Sublingual Film (CIII) Talking with your doctor Opioid dependence can be treated. Talking with your healthcare team keeps them aware of your situation so they may
More informationThe science of the mind: investigating mental health Treating addiction
The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with
More informationIdentification and Treatment of Opioid Use Disorders in Primary Care Settings
Identification and Treatment of Opioid Use Disorders in Primary Care Settings 17th Annual Primary Care Symposium February 24, 2018 Kelly S. Barth, DO Associate Professor, Psychiatry & Internal Medicine
More informationKurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center
Kurt Haspert, MS, CRNP University of Maryland Baltimore Washington Medical Center Data from the National Vital Statistics System Mortality The age-adjusted rate of drug overdose deaths in the United States
More informationGOALS AND OBJECTIVES
SUBOXONE AND VIVITROL: ARE THERE DISPARITIES SURFACING IN MEDICATION ASSISTED TREATMENTS? P R E S E N T E D B Y D R. K I AM E M AH A N I A H & D R. M Y E C H I A M I N T E R - J O R D AN GOALS AND OBJECTIVES
More informationWelcome to the Opioid Overdose Prevention Project
Welcome to the Opioid Overdose Prevention Project Narcan Training TODAY S OBJECTIVES Define drug addiction Identify symptoms of addiction Treatment options including support for family members How to recognize
More informationWhat Is Heroin? Examples of Opioids. What Science Says about Opioid Use Disorder and Its Treatment 6/27/2016
What Science Says about Opioid Use Disorder and Its Treatment Perilou Goddard, Ph.D. Department of Psychological Science Northern Kentucky University Examples of Opioids Agonists (activate opioid receptors)
More informationInitiation of Medication in Treating Opioid Use Disorder.
Initiation of Medication in Treating Opioid Use Disorder. Colleen T. LaBelle MSN RN-BC CARN Program Director STATE OBAT B Nurse Manager Boston Medical Center OBAT Executive Director MA IntNSA *Images used
More informationSlide 1. Slide 2. Slide 3. Opioid (Narcotic) Analgesics and Antagonists. Lesson 6.1. Lesson 6.1. Opioid (Narcotic) Analgesics and Antagonists
Slide 1 Opioid (Narcotic) Analgesics and Antagonists Chapter 6 1 Slide 2 Lesson 6.1 Opioid (Narcotic) Analgesics and Antagonists 1. Explain the classification, mechanism of action, and pharmacokinetics
More information(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)
Buprenorphine Initiation and Maintenance in Pregnancy (Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Assessment The diagnosis of OUD should be confirmed by DSM-5
More informationhow long does tramadol withdrawal last?? i was on tramadol for about 2 weeks and this is my third day without tramadol you think how much
18-10-2014 how long does last?? i was on tramadol for about 2 weeks and this is my third day without tramadol you think how much time left to. At the same how long does last,. How long does last from tramadol.
More informationVivitrol Drug Court and Medication Assisted Treatment
Vivitrol Drug Court and Medication Assisted Treatment Amy Black, CNP and Judge Fred Moses Court program Self-starters Mission Statement To provide court-managed, medically assisted drug intervention treatment
More informationBuprenorphine treatment
South London and Maudsley NHS Foundation Trust Buprenorphine treatment Information for service users Page Buprenorphine treatment What is buprenorphine? Buprenorphine (trade name Subutex ) is an opioid
More informationCharles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus
Pain & Opioid Epidemic 2018 Charles P. O Brien, MD, PhD University of Pennsylvania No financial conflicts, patents, speakers bureaus Opioids 3400 BC Mesopotamia, Joy plant 1843 morphine by syringe 1874
More informationLONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE
LONG TERM PHARMACOTHERAPY OF OPIOID DEPENDENCE DR. SHILPA ADARKAR ASSOCIATE PROFESSOR DEPARTMENT OF PSYCHIATRY & DRUG DEADDICTION CENTRE OF EXCELLENCE SETH GSMC & KEMH LONG TERM OPTIONS FULL AGONIST PARTIAL
More informationWITHDRAWING FROM BUPRENORPHINE THERAPY
WITHDRAWING FROM BUPRENORPHINE THERAPY VARIOUS REASONS TO STOP BUPRENORPHINE pregnancy and lactation emergency surgery/elective surgery difficult to manage side effects of buprenorphine patients showing
More informationDrug & Alcohol Detox:
Drug & Alcohol Detox: Beginning Stages of Addiction Treatment If you ve tried to detox on your own and failed, you are not alone. The good news is that research shows those who commit to a rehabilitation
More informationDISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.
DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this
More informationAlternatives to Buprenorphine
Alternatives to Buprenorphine Charles Morgan, MD, FASAM, FAAFP Medical Director Bridgeton, NJ Westfield, PA New York, NY Cherry Hill, NJ Northfield, NJ 1 2 Heroin Purity increasing Pharmaceuticals Expense
More informationPolicy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04
Policy on Pharmacological Therapies Practice Guidance Note Reducing Dosing Errors with Opioid Medicines V04 Date issued Issue 1 Nov 2018 Planned review Nov 2021 PPT-PGN 18 part of NTW(C)38 Pharmaceutical
More informationROSC & MAT II: Opioid Treatment Services
ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify
More informationMedication-Assisted Treatment (MAT) for Opioid Use Disorders
Medication-Assisted Treatment (MAT) for Opioid Use Disorders Sybil Marsh MA MD FASAM Department of Family Medicine and Community Health Case Western Reserve University/UHCMC Learning Objective 1 Following
More informationAnalgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015
Analgesia for Patients with Substance Abuse Disorders Lisa Jennings CN November 2015 Definitions n Addiction: A pattern of drug use characterised by aberrant drug-taking behaviours & the compulsive use
More informationSUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets. Risk Evaluation and Mitigation Strategy (REMS) Program
SUBOXONE Film, SUBOXONE Tablets, and SUBUTEX Tablets Risk Evaluation and Mitigation Strategy (REMS) Program Office-Based Buprenorphine Therapy for Opioid Dependence: Important Information for Prescribers
More informationOverview of Opioid Use Disorder
Overview of Opioid Use Disorder Doug Burgess, MD Medical Director of Outpatient Services, Truman Medical Centers Assistant Professor of Psychiatry, University of Missouri- Kansas City Objectives History
More informationMAT - ICAAD 2018 Ron Jackson, MSW, LICSW
The ATTC Network Ten Regional Centers northwest@attcnetwork.org www.attcnetwork.org/northwest phone. 206-685-4419 1107 NE 45 th St, Ste 120, Seattle, WA 98105 http://attcnetwork.org/northwest U.S. Opioid
More informationTuscarawas County Health Department. Vivitrol Treatment Consent
Tuscarawas County Health Department Vivitrol Treatment Consent I. Vivitrol Medication Guide: a. VIVITROL (viv-i-trol) (naltrexone for extended-release injectable suspension) b. Read this Medication Guide
More information8/28/2017. Headlines. How Did We Get Here? Pain is the number one reason patients go the doctors office, urgent care and/or emergency room.
Ashel Kruetzkamp, MSN, RN, SANE Headlines How Did We Get Here? Pain is the number one reason patients go the doctors office, urgent care and/or emergency room. Opiates are the most effective pain medication
More informationPrescription Opioids
What are prescription opioids? Prescription Opioids Opioids are a class of drugs naturally found in the opium poppy plant. Some prescription opioids are made from the plant directly, and others are made
More informationAddiction to Opioids. Marvin D. Seppala, MD Chief Medical Officer
Addiction to Opioids Marvin D. Seppala, MD Chief Medical Officer Mayo Clinic Opioid Conference: Evidence, Clinical Considerations and Best Practice Friday, September 30, 2016 26 y.o. female from South
More informationMedication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc.
Medication Assisted Treatment: Right for you, Right for your Recovery? Robert Matylewicz, DO, FASAM Medical Director, Clarity Way Inc. Elements Behavioral Health Diplomate, American Board of Addiction
More informationSteven Prakken MD Director Medical Pain Service Duke Pain Medicine
Steven Prakken MD Director Medical Pain Service Duke Pain Medicine Misuse Abuse Addiction Total Pain Population Webster LR, Webster RM. Pain Med. 2005;6(6):432-442. DSM IV Abuse defined as 2 elements
More informationOpioid Use in Pregnant Women and Prenatal Care. Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard
Opioid Use in Pregnant Women and Prenatal Care Murray F Dweck MD, FACOG Medical Director/OBGYN Florida Department of Health -Brevard Objectives Summarize contextual and co-morbid factors observed among
More informationOST. Pharmacology & Therapeutics. Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO
OST Pharmacology & Therapeutics Leo O. Lanoie, MD, MPH, FCFP, CCSAM, ABAM, MRO Disclaimer In the past two years I have received no payment for services from any agency other than government or academic.
More informationOpioid Step Policy. Description. Section: Prescription Drugs Effective Date: April 1, 2018
Federal Employee Program 1310 G Street, N.W. Washington, D.C. 20005 202.942.1000 Fax 202.942.1125 Subject: Opioid Step Policy Page: 1 of 6 Last Review Date: March 16, 2018 Opioid Step Policy Description
More informationMethadone and Naltrexone ER
Methadone and Naltrexone ER Laura G. Kehoe, MD, MPH, FASAM Medical Director MGH Substance Use Disorder Bridge Clinic Assistant Professor of Medicine Harvard Medical School Disclosures Neither I nor my
More informationWR Fentanyl Symposium. Opioids, Overdose, and Fentanyls
Opioids, Overdose, and Fentanyls Outline: What are opioids? Why are we experiencing and opioid crisis? Potency, purity, and product How do opioids cause overdose and overdose deaths? What is naloxone and
More informationMedications for Opioid Use Disorder. Charles Brackett, MD, MPH General Internal Medicine, DHMC
Medications for Opioid Use Disorder Charles Brackett, MD, MPH General Internal Medicine, DHMC Opioid Related Deaths are on the Rise in the US National Vital Statistics System Mortality File Deaths are
More informationDr Alistair Dunn. General Practitioner Whangarei
Dr Alistair Dunn General Practitioner Whangarei 1982 Temgesic = Buprenorphine Sublingual opiate analgesic 0.2 mg Popular drug of abuse 1991 Temgesic NX = Bup & Nalxone Nalxone added to deter abuse 1999
More informationBuprenorphine as a Treatment Option for Opioid Use Disorder
Buprenorphine as a Treatment Option for Opioid Use Disorder Joji Suzuki, MD Assistant Professor of Psychiatry Harvard Medical School Director, Division of Addiction Psychiatry Brigham and Women s Hospital
More informationThe missed diagnosis. Melinda Allen, DO, FACOI
The missed diagnosis Melinda Allen, DO, FACOI 62 year old female Previous patient, not seen in 3 years Referred to office for PT/INR control by cardiologist due to difficulty for past 12 months. Mechanical
More informationXanax help with opiate withdrawal
Xanax help with opiate withdrawal The Borg System is 100 % Xanax help with opiate withdrawal Mar 11, 2015. Subutex contains just buprenorphine without naloxone, and so while you won't go into withdrawal
More informationArwen Podesta, MD. ABIHM, ABAM, Forensic Psychiatry
The State of Medicine in Addiction Recovery Arwen Podesta, MD ABIHM, ABAM, Forensic Psychiatry www.podestawellness.com 504-252-0026 http://www.addictionpolicy.org/ Overview Addiction is a serious, chronic
More informationNational Council on Patient Information and Education
National Council on Patient Information and Education You are not alone The type of pain that caused your doctor to prescribe a pain medicine for you can make you feel that you are different from everyone
More informationOpioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue
Opioids- Indica-ons, Equivalence, Dependence and Withdrawal Methadone Maintenance (OST) Paul Glue Scope Pharmacology of Opioids Equivalence Dependence and Withdrawal Methadone Maintenance (OST) 3 Opioid
More informationAryeh Levenson, M.D. (ext 8597) March 26, 2012 SUBOXONE PROGRAM:
Aryeh Levenson, M.D. alevenson@scf.cc (ext 8597) March 26, 2012 SUBOXONE PROGRAM: Opiate Addiction: History First seriously emerged iatrogenically with Civil War vets By late 19 th century, 2/3 of all
More informationNALTREXONE DAVID CRABTREE, MD, MPH UNIVERSITY OF UTAH HEALTH, 2018
NALTREXONE DAVID CRABTREE, MD, MPH TREATMENT OF OPIOID USE DISORDER (OUD) Majority of people who develop OUD are not receiving treatment Only a small fraction of patients are offered treatment with medications
More informationUnderstanding Medication in Addiction Treatment for Drug Court Participants
Understanding Medication in Addiction Treatment for Drug Court Participants Introduction This pocket guide is for drug court participants who may be prescribed or considering medication as a part of addiction
More informationH NDS-ONHealth. Prescription Drug Abuse. Drug overdose death rates in the United States have more than tripled since 1990 and have never been higher.
H NDS-ONHealth Health Wave Newsletter, October 2013 Visit us on our website at www.healthwaveinc.com Drug overdose death rates in the United States have more than tripled since 1990 and have never been
More informationBuprenorphine for Family Medicine. Hannah Snyder, MD Addiction Medicine Fellow, UCSF 12/7/17
+ Buprenorphine for Family Medicine Hannah Snyder, MD Addiction Medicine Fellow, UCSF 12/7/17 + Disclosures No conflicts of interest Off-label use of medications + Who here: Has taken care of a patient
More informationthe facts about BUPRENORPHINE for Treatment of Opioid Addiction
the facts about BUPRENORPHINE for Treatment of Opioid Addiction i I d been shot on the streets, I d been in detox. It was jails, institutions. Death, I knew, was imminent for me so I started my recovery
More informationPharmacotherapy for opioid addiction. Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco
Pharmacotherapy for opioid addiction Judith Martin, MD Medical Director BAART Turk Street Clinic San Francisco Disclosure slide No commercial conflicts to disclose. Gaps in current treatment of opioid
More informationLatest Press Release. How much for 30 mg adderall
corp@stantec.com Latest Press Release How much for 30 mg adderall S 14-2-2008 Hi my name is Rachel i have been on suboxone for almost a year as of OCT 1st, and I have become the person I guess I am to
More informationUSE OF BUPRENORPHINE FOR CHRONIC PAIN
Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences USE OF BUPRENORPHINE FOR CHRONIC PAIN MARK SULLIVAN, MD, PHD PSYCHIATRY AND BEHAVIORAL SCIENCES ANESTHESIOLOGY AND
More informationMedical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center
Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers
More informationOpioid Use in Youth. Amy Yule M.D. March 2,
Opioid Use in Youth Amy Yule M.D. March 2, 2018 An opioid is a substance that acts on opioid receptors Beta-endorphin Endogenous opioids Dynorphin Opiates Natural products of the poppy plant Morphine Heroin
More information